Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members
Status:
Completed
Trial end date:
1990-03-01
Target enrollment:
Participant gender:
Summary
To determine the safety and effectiveness of a combination chemotherapy-radiation-zidovudine
(AZT) treatment for patients with peripheral lymphoma.
Other chemotherapies have been tried in patients with AIDS related lymphomas, but the results
have not been satisfactory. This study will show whether the combination of chemotherapy,
radiation, and AZT is more effective and less toxic than previously used treatments.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)